Alzheimer’s Disease Treatment: Canadian-Led Innovation…
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for Alzheimer’s Disease (AD)…
Tagged with Biogen
Biogen Canada’s Marina Vasiliou: A 100% Commitment to…
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of…
Martin Dubuc – General Manager, Biogen France
Martin Dubuc, general manager of Biogen France, discusses the company’s strong leadership in neurosciences, its commitment to pioneering the…
Biogen: The Only Hope for Alzheimer’s?
After completing Phase II of clinical trials, Biogen and Eisai’s new candidate drug for Alzheimer’s Disease is showing strong potential in a field…
Brexit: A Serious Threat to Patients
As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are split on the implications of Brexit…
Interview: Terry O'Regan – Vice President and Managing…
Terry O’Regan, VP and managing director at Biogen UK and Ireland, discusses the company’s longstanding commitment to the UK, market access issues,…
Marina Vasiliou – Managing Director, Biogen Canada
At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her…
Interview: Sameer Savkur – Country Manager, Biogen Brazil
Sameer Savkur, country manager of Biogen Brazil, provides insights into the key specificities of the Brazilian pharmaceutical ecosystem and documents…
Mapping Swiss Pharma
It is tempting to characterize Switzerland’s global pharma and life science hotspots as beginning and ending with Basel – home of industry giants…
Interview: Elena Strapkova Boydova – Country Director,…
Biogen Slovakia’s Country Director on being an innovative global biotech in Slovakia, market access in the country, and the company’s…
Interview: Natascha Schill – Managing Director, Biogen…
MD Natascha Schill discusses the growing importance and commitment that Biogen has to Switzerland, including a USD one billion investment in new…
Interview: Michaela Hrdlickova – Country Director, Biogen,…
Michaela Hrdlickova of Biogen elaborates on how it is the industry’s responsibility to educate all stakeholders within the Czech Republic in order…
